Pacific Biosciences of California, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Pacific Biosciences of California, Inc. (PACB) had Operating Lease, Weighted Average Discount Rate, Percent of 10.20% as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-02-25
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 10.20%.
- 2025-03-31: Operating Lease, Weighted Average Discount Rate, Percent 10.10%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 7.70%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.80%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 10.20% 10-K · filed 2026-02-25 |
| 2025-03-31 | 10.10% 10-Q · filed 2025-05-12 |
| 2024-12-31 | 7.70% 10-K · filed 2025-03-17 |
| 2023-12-31 | 6.80% 10-K · filed 2024-02-28 |
| 2022-12-31 | 6.70% 10-K · filed 2023-02-28 |
| 2021-12-31 | 6.70% 10-K · filed 2022-02-28 |
| 2021-09-30 | 6.80% 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |